Figure 1From: Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West AfricaTrial profile (90 day follow-up). LCF: late clinical failure. ETF: early treatment failure. CQ: Chloroquine; SP: Sulphadoxine-Pyrimethamine; AS: Artesunate. LFU: Lost to follow-up; FU: Follow-up.Back to article page